日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Identifying obstacles hindering the conduct of academic-sponsored trials for drug repurposing on rare-diseases: an analysis of six use cases

识别阻碍学术机构资助的罕见病药物再利用试验开展的障碍:六个用例分析

Del Álamo, Marta; Bührer, Christoph; Fisher, Dirk; Griese, Matthias; Lingor, Paul; Palladini, Giovanni; Sireau, Nicolas; Hivert, Virginie; Sangiorgi, Luca; Guillot, Florence; Halftermeyer, Juliane; Soucková, Lenka; Nosková, Kristýna; Demlová, Regina

The importance of international collaboration for rare diseases research: a European perspective

国际合作对罕见病研究的重要性:欧洲视角

Julkowska, D; Austin, C P; Cutillo, C M; Gancberg, D; Hager, C; Halftermeyer, J; Jonker, A H; Lau, L P L; Norstedt, I; Rath, A; Schuster, R; Simelyte, E; van Weely, S

Seroprevalence of cytomegalovirus infection in France in 2010

2010年法国巨细胞病毒感染血清阳性率

Antona, D; Lepoutre, A; Fonteneau, L; Baudon, C; Halftermeyer-Zhou, F; LE Strat, Y; Lévy-Bruhl, D